New Technologies for Sentinel Lymph Node Detection

被引:32
作者
Goyal, Amit [1 ]
机构
[1] Royal Derby Hosp, Dept Surg, Uttoxeter Rd, Derby DE22 3NE, England
关键词
Computed tomography lymphography; Fluorescein; Indocyanine green; Microbubbles; Sentinel lymph node biopsy; Superparamagnetic iron oxide; SPIO; INDOCYANINE GREEN FLUORESCENCE; SUPERPARAMAGNETIC IRON-OXIDE; STAGE BREAST-CANCER; RADIOTRACER METHOD; AXILLARY TREATMENT; BIOPSY; TRIAL; ULTRASOUND; METAANALYSIS; SENTIMAG;
D O I
10.1159/000492436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The standard of care' method for sentinel node mapping is the combination technique using radioisotope and blue dye although some centres use radioisotope or blue dye alone. Radioisotope usage requires licensing, has regulatory issues around handling and disposal of waste, and logistically may be unavailable or difficult to implement in some centres or less developed country. This has led to the development of alternative methods such as superparamagnetic iron oxide (SPIO), fluorescence techniques using indocyanine green (ICG) or fluorescein, computed tomography lymphography, and contrast-enhanced ultrasound scan (CEUS) using microbubbles. The newer techniques will potentially enable a more widespread adoption of this procedure; however, a common barrier for these techniques is the lack of standardisation and no randomised trials to evaluate their effectiveness against the current standard of care. Furthermore, many of these techniques are more costly and may become redundant in node-negative patients with small tumours if ongoing trials show that sentinel node biopsy offers no additional benefit to grey-scale axillary ultrasound. This review discusses the new techniques for sentinel node mapping that have emerged including their pros and cons. (C) 2018 S. Karger GmbH, Freiburg
引用
收藏
页码:349 / 353
页数:5
相关论文
共 43 条
  • [1] The combination of preoperative computed tomography lymphography and intraoperative fluorescence imaging navigation for sentinel lymph node biopsy of early breast cancer patients.
    Abe, Hajime
    Teramoto, Atsuko
    Yamasaki, Keiichi
    Yoneda, Kohri
    Ogawa, Masao
    Kawasaki, Masayasu
    Kameyama, Masao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review
    Ahmed, Muneer
    Purushotham, Arnie D.
    Douek, Michael
    [J]. LANCET ONCOLOGY, 2014, 15 (08) : E351 - E362
  • [3] The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: A concordance and validation study
    Ballardini, B.
    Santoro, L.
    Sangalli, C.
    Gentilini, O.
    Renne, G.
    Lissidini, G.
    Pagani, G. M.
    Toesca, A.
    Blundo, C.
    del Castillo, A.
    Peradze, N.
    Caldarella, P.
    Veronesi, P.
    [J]. EJSO, 2013, 39 (12): : 1332 - 1336
  • [4] Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience
    Barthelmes, L.
    Goyal, A.
    Newcombe, R. G.
    McNeill, F.
    Mansel, R. E.
    [J]. EJSO, 2010, 36 (04): : 399 - 403
  • [5] 1% lymphazurin vs 10% fluorescein for sentinel node mapping in colorectal tumors
    Dan, AG
    Saha, S
    Monson, KM
    Wiese, D
    Schochet, E
    Barber, KR
    Ganatra, B
    Desai, D
    Kaushal, S
    [J]. ARCHIVES OF SURGERY, 2004, 139 (11) : 1180 - 1184
  • [6] Sentinel Node Biopsy Using a Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial
    Douek, Michael
    Klaase, Joost
    Monypenny, Ian
    Kothari, Ashutosh
    Zechmeister, Katalin
    Brown, Douglas
    Wyld, Lynda
    Drew, Philip
    Garmo, Hans
    Agbaje, Olorunsola
    Pankhurst, Quentin
    Anninga, Bauke
    Grootendorst, Maarten
    ten Haken, Bennie
    Hall-Craggs, Margaret A.
    Purushotham, Arnie
    Pinder, Sarah
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (04) : 1237 - 1245
  • [7] Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
    Galimberti, Viviana
    Cole, Bernard F.
    Zurrida, Stefano
    Viale, Giuseppe
    Luini, Alberto
    Veronesi, Paolo
    Baratella, Paola
    Chifu, Camelia
    Sargenti, Manuela
    Intra, Mattia
    Gentilini, Oreste
    Mastropasqua, Mauro G.
    Mazzarol, Giovanni
    Massarut, Samuele
    Garbay, Jean-Remi
    Zgajnar, Janez
    Galatius, Hanne
    Recalcati, Angelo
    Littlejohn, David
    Bamert, Monika
    Colleoni, Marco
    Price, Karen N.
    Regan, Meredith M.
    Goldhirsch, Aron
    Coates, Alan S.
    Gelber, Richard D.
    Veronesi, Umberto
    [J]. LANCET ONCOLOGY, 2013, 14 (04) : 297 - 305
  • [8] Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)
    Gentilini, Oreste
    Veronesi, Umberto
    [J]. BREAST, 2012, 21 (05) : 678 - 681
  • [9] The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment
    Ghilli, M.
    Carretta, E.
    Di Filippo, F.
    Battaglia, C.
    Fustaino, L.
    Galanou, I.
    Di Filippo, S.
    Rucci, P.
    Fantini, M. P.
    Roncella, M.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (04)
  • [10] Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? One-Year Outcomes of Sentinel Node Biopsy Versus Axillary Clearance (SNAC): A Randomized Controlled Surgical Trial
    Gill, Grantley
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (02) : 266 - 275